SAX notes that testing requirements do not automatically change when rescheduling occurs, as they remain governed by state law and federal legal status remains unresolved.
Public source
Publisher name
Public post
While we are waiting on rescheduling, I wanted to pass on a few things: 1. Rescheduling does not turn dispensary products into FDA-approved drugs. 2. Testing requirement…
Company
SAX
- Industry
- Accounting
- Location
- Parsippany, US
- Company size
- 501–1,000 employees
About SAX
SAX is a multi-disciplinary accounting, tax and advisory firm serving the needs of privately held companies, family-owned businesses, not-for-profit organizations and high-net-worth individuals. For more than 65 years, we have offered industry-specific expertise, comprehensive service offerings and client-centric results. “SAX” is the brand name under which SAX LLP and SAX Advisory Group LLC and its subsidiary entities provide professional services. Our advisors are passionate, forward-thinking entrepreneurs who are driven to see their clients succeed. Through our unique Client Service Delivery Model, we offer the right business solutions to help our clients turn their dreams and vision into reality. With offices in Parsippany, N.J., Ewing, N.J. Morganville, NJ and New York City, we have a keen sense of what it takes to succeed in this competitive and ever-changing marketplace. Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Sax Capital Advisors is not a registered broker-dealer, and Finalis Securities LLC and Sax Capital Advisors are separate, unaffiliated entities.
See moreLatest activity
Latest activity from SAX
8 signals
Presence & Recognition
SAX hosted a Sneaker Drive at the Embassy Suites in Saratoga for networking and sneakers, collecting more than 50 pairs of sneakers and accepting donations through the end of next week.
Presence & Recognition
SAX is hosting the 15th Annual SAX 4 MILER event in Parsippany, New Jersey, on September 19 to benefit St. Joseph Health's Children's Hospital.
Presence & Recognition
SAX hosted an event hosted by the ACBA Young Lawyers Committee.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
CohnReznick
CohnReznick reports that bipartisan lawmakers are focusing on regulating hemp-derived THC products as legislation delaying the scheduled federal restrictions appears poised to be enacted.
Legal & Regulatory
Dickinson Wright
Dickinson Wright noted that the DEA concluded its hearing to determine whether cannabis products sold to adult use customers should be treated as Schedule III drugs under the Controlled Substances Act.
Legal & Regulatory
Luna Stower Strategies
Luna Stower Strategies notes that state-medical cannabis and FDA-approved products moved into Schedule III this year.
Legal & Regulatory
Bradley Arant Boult Cummings LLP
Bradley Arant Boult Cummings LLP reported that the DEA is arguing that marijuana doesn’t belong in Schedule I, while seven groups it hand-picked to participate in the hearing are fighting to keep it there.
Legal & Regulatory
Levin Ginsburg